PPT-Why, when & How to add Prandial insulin after Basal Optimization

Author : lucy | Published Date : 2023-07-27

FOCUS OF PROFILE GLULISINE The main target To normalize Blood glucose Delay progression Reduce complication s Diabetes Management ᵛ ᵛ fasting postprandial

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Why, when & How to add Prandial insu..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Why, when & How to add Prandial insulin after Basal Optimization: Transcript


FOCUS OF PROFILE GLULISINE The main target To normalize Blood glucose Delay progression Reduce complication s Diabetes Management ᵛ ᵛ fasting postprandial 1Fasting hyperglycemia . the Treatment of T1DM and T2DM. Lawrence Blonde, MD, FACP, FACE. Director of the . Ochsner. Diabetes Clinical Research Unit. Ochsner. Medical Center. New Orleans, Louisiana. Vivian . A. Fonseca, MD, FRCP. G. lucose . C. ontrol. Mary Catherine . MacSween. MD FRCPC. The Moncton Hospital . Case DM. 74 year old male DM1 x 40 years.. MDI with . Levemir. 17 units . hs. and . NovoRapid. at meals.. Pre-op instructions take half usual . Tom Blevins MD. Texas Diabetes and Endocrinology. Austin, Texas. Stem Cell Breakthrough . In a breakthrough that signifies a move toward a cure for type 1 diabetes, Australian researchers have identified stem cells in the pancreas that can be turned into insulin-producing cells..... The Basal Bolus order set is intended for the management of hospitalized patients with poorly controlled blood glucose (greater than 140 mg/. dL. random blood sugar). The Basal Bolus Insulin Order Set. Program Goals. The . Incretin System: Response to Oral Glucose. Injected Incretin-based Agents: GLP-1 Receptor Agonists. Oral Incretin-based Agents: DPP-4 Inhibitors . Main Pathophysiological Defects in T2D. GLP-1 RAs in Combination With Basal Insulin Approved by US FDA. Why Combine a GLP-1 RA With Basal Insulin?. Adding Prandial Insulin to Basal Insulin . Exenatide Once Weekly Now Approved for Use With Basal Insulin. August 18, 2017. Disclaimer. This activity features cases that are loosely based on two famous musicians who had diabetes: Jerry Garcia and Ella Fitzgerald. Publicly available medical information was used to construct the core elements of the cases. When information was not available, the activity content planners added relevant, but fictional, details to devise an meaningful educational experience.  . Novelty 1: Ice thickness is allowed to vary during the optimization (but constrained by observational uncertainties) to provide another degree of freedom. Probabilistic Sea-Level Projections from Ice Sheet and Earth System Models 3:  Insulin and Incretins: the perfect Partnership? Stephen Colagiuri, MD Professor of Metabolic Health Boden Institute of Obesity, Nutrition and Exercise University of Sydney Sydney, Australia Moderator Dr. . . Ghadiri. , MD. Assistance professor of endocrinology. Shahid. . Sadoughi. . University of Medical Sciences . 2. The importance of glycemic control in minimizing complications related to diabetes has been well established in type 1 diabetes . Markus Menzen. 1. ; Niels Væver Hartvig. 2. ; Anne Kaas. 2. ; Nikoline Nygård Knudsen. 2. ; Johan Jendle. 3. 1. Division of Internal Medicine, Department of Gastroenterology and Diabetology, Community Hospital Bonn, Bonn, Germany. Diabetes Educator. Program Coordinator . Diabetes Resource Center . Hopkinsville, KY.. Disclosure. to Participants. Notice of Requirements For Successful Completion. Please refer to learning goals and objectives. I Wear My Pancreas on the Outside: Insulin Pump and CGM Basics. Clinical Dietitian/Certified . D. iabetes . E. ducator. Brody School of Medicine at East Carolina University. Pediatric Specialty Care . Research Institute For Endocrine Sciences. Endocrine Research Center. Shahid Beheshti University. 04.04.1397. Outlines. Case presentation. Barriers of insulin therapy. Action-profile. Types of basal .

Download Document

Here is the link to download the presentation.
"Why, when & How to add Prandial insulin after Basal Optimization"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents